The commonly used over-the-counter (OTC) medications panadol and paracetamol may be unavailable in markets due to the manufacturer of the brands discontinuing production of both medications.
Panadol, a generic medication, is used to treat vaccine-shot soreness, minor headaches, and fevers.
The reason for discontinuing production is cost-effectiveness.
The company claims that production is no longer economically beneficial and has petitioned authorities to raise the price of Panadol.
A pharmaceutical company has stopped the production of its popular #paracetamol brand #Panadol creating a nationwide shortage. The company, which has been demanding permission to increase Panadol price, says that production was no longer cost-effective. #theCivileyes pic.twitter.com/kRaXdnDaXC— TheCivilEyes (@TheCivilEyes) September 11, 2022
According to the Pharmaceutical Manufacturing Association of Pakistan, the Drug Regulatory Authority of Pakistan (DRAP) reportedly sent a summary to the Health Ministry requesting an increase of Rs 1 per medicine, but the federal cabinet rejected the request.
Pakistan no longer manufactures Panadol; a shortage is expected. The manufacturer could not sell the medicine for less than the cost of production. The pharmaceutical industry claims that tablet production has stopped totally.